Eviplera emtricitabine/tenofovir/rilpivirine regulatory update

Gilead withdrew its application to extend the use of Eviplera emtricitabine/tenofovir/rilpivirine to treat HIV-1 infection in previously untreated adult patients to include those with a viral load bet...